Virpax Pharmaceuticals Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $11.77 on 06/23/23, and the lowest price during the same period was recorded at $2.40 on 12/14/23.
52-week price history of VRPX Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Virpax Pharmaceuticals Inc’s current trading price is -57.96% away from its 52-week high, while its distance from the 52-week low is 106.08%. The stock’s price range during this period has fluctuated between $2.40 and $11.77. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 0.54 million for the day, which was evidently higher than the average daily volume of 31660.0 over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Virpax Pharmaceuticals Inc (VRPX) has experienced a quarterly rise of 25.32% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 5.79M and boasts a workforce of 7 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 4.53, with a change in price of -2.85. Similarly, Virpax Pharmaceuticals Inc recorded 27,161 in trading volume during the last 100 days, posting a change of -36.55%.
VRPX Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for VRPX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
VRPX Stock Stochastic Average
The raw stochastic average for Virpax Pharmaceuticals Inc over the last 50 days is presently at 81.95%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 81.34%. Further, the company’s Stochastic %K and %D values for the last 20 days were 84.70% and 84.04%, respectively.
VRPX Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The index has shown a price gain of 54.64% this year. Over the last six months, there has been a stronger performance of -41.02%. The price of VRPX fallen by 32.14% during the last 30 days period. For the last 5-days stocks have improved 31.47%.
